Zafgen to Present at the JMP Securities Life Sciences Conference Read more about Zafgen to Present at the JMP Securities Life Sciences Conference Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions Read more about Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions Zafgen Announces Regulatory Update on ZGN-1061 Read more about Zafgen Announces Regulatory Update on ZGN-1061 Zafgen Reports First Quarter 2019 Operating and Financial Results Read more about Zafgen Reports First Quarter 2019 Operating and Financial Results Zafgen to Announce First Quarter 2019 Financial Results Read more about Zafgen to Announce First Quarter 2019 Financial Results Zafgen, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Read more about Zafgen, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Zafgen to Present at the 31st Annual ROTH Conference Read more about Zafgen to Present at the 31st Annual ROTH Conference Zafgen Reports Fourth Quarter and Full Year 2018 Operating and Financial Results and Provides Key Program and Business Updates Read more about Zafgen Reports Fourth Quarter and Full Year 2018 Operating and Financial Results and Provides Key Program and Business Updates Zafgen to Present at the Cowen and Company 39th Annual Health Care Conference Read more about Zafgen to Present at the Cowen and Company 39th Annual Health Care Conference Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results Read more about Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last » Subscribe to
Zafgen to Present at the JMP Securities Life Sciences Conference Read more about Zafgen to Present at the JMP Securities Life Sciences Conference
Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions Read more about Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions
Zafgen Announces Regulatory Update on ZGN-1061 Read more about Zafgen Announces Regulatory Update on ZGN-1061
Zafgen Reports First Quarter 2019 Operating and Financial Results Read more about Zafgen Reports First Quarter 2019 Operating and Financial Results
Zafgen to Announce First Quarter 2019 Financial Results Read more about Zafgen to Announce First Quarter 2019 Financial Results
Zafgen, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Read more about Zafgen, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Zafgen to Present at the 31st Annual ROTH Conference Read more about Zafgen to Present at the 31st Annual ROTH Conference
Zafgen Reports Fourth Quarter and Full Year 2018 Operating and Financial Results and Provides Key Program and Business Updates Read more about Zafgen Reports Fourth Quarter and Full Year 2018 Operating and Financial Results and Provides Key Program and Business Updates
Zafgen to Present at the Cowen and Company 39th Annual Health Care Conference Read more about Zafgen to Present at the Cowen and Company 39th Annual Health Care Conference
Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results Read more about Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results